O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5665772
SERIAL NO

08416673

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel derivatives of rapamycin, particularly 9-deoxorapamycins, 26-dihydro-rapamycins, and 40-0-substituted and 28,40-0,0-di-substituted rapamycins, are found to have pharmaceutical utility, particularly as an immunosuppressants.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NOVARTIS AG;SANDOZ LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cottens, Sylvain Witterswil, CH 27 417
Sedrani, Richard Basel, CH 25 457

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation